We identify the pivotal role of CYP3A5 in this process and thus establish a robust foundation for future investigations aimed at leveraging the therapeutic potential of CYP3A5 in GBM treatment (Fig. 8). The gene discussed is CYP3A5; the disease is glioblastoma.